Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zobel

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 8, 2020
Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta-analysisNatja Launbo, Emilie H Zobel, Bernt Johan von Scholten, et al.
Diabetes, Obesity & Metabolism|October 22, 2021
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trialsEmilie H Zobel, Bernt Johan von Scholten, Tine W Hansen, et al.
Diabetes Care|January 8, 2017
Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 DiabetesEmilie H Zobel, Simone Theilade, Bernt Johan von Scholten, et al.
European Heart Journal. Cardiovascular Imaging|December 12, 2018
Myocardial flow reserve assessed by cardiac 82Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetesEmilie H Zobel, Signe A Winther, Philip Hasbak, et al.
Scientific Reports|September 18, 2021
Effect of liraglutide on expression of inflammatory genes in type 2 diabetesEmilie H Zobel, Rasmus S Ripa, Bernt J von Scholten, et al.
Diabetologia|July 7, 2017
Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.
Frontiers in Endocrinology|December 17, 2021
Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [<sup>64</sup>Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME TrialJacob K Jensen, Emilie H Zobel, Bernt J von Scholten, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Effect of Liraglutide on Vascular Inflammation Evaluated by [<sup>64</sup>Cu]DOTATATEEmilie H Zobel, Rasmus S Ripa, Bernt J von Scholten, et al.
Cardiovascular Diabetology|July 13, 2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.
Cell Reports|May 19, 2026
PARP1-specific inhibitor displays PARP1-detrapping activityKira Schützenhofer, Ellen Laker, Kyle Tsang, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 8, 2020
Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta-analysisNatja Launbo, Emilie H Zobel, Bernt Johan von Scholten, et al.
Diabetes, Obesity & Metabolism|October 22, 2021
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trialsEmilie H Zobel, Bernt Johan von Scholten, Tine W Hansen, et al.
Diabetes Care|January 8, 2017
Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 DiabetesEmilie H Zobel, Simone Theilade, Bernt Johan von Scholten, et al.
European Heart Journal. Cardiovascular Imaging|December 12, 2018
Myocardial flow reserve assessed by cardiac 82Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetesEmilie H Zobel, Signe A Winther, Philip Hasbak, et al.
Scientific Reports|September 18, 2021
Effect of liraglutide on expression of inflammatory genes in type 2 diabetesEmilie H Zobel, Rasmus S Ripa, Bernt J von Scholten, et al.
Diabetologia|July 7, 2017
Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.
Frontiers in Endocrinology|December 17, 2021
Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [<sup>64</sup>Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME TrialJacob K Jensen, Emilie H Zobel, Bernt J von Scholten, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Effect of Liraglutide on Vascular Inflammation Evaluated by [<sup>64</sup>Cu]DOTATATEEmilie H Zobel, Rasmus S Ripa, Bernt J von Scholten, et al.
Cardiovascular Diabetology|July 13, 2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.
Cell Reports|May 19, 2026
PARP1-specific inhibitor displays PARP1-detrapping activityKira Schützenhofer, Ellen Laker, Kyle Tsang, et al.
Pageof 4